The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Transcatheter Structural Heart Device Market Research Report 2024

Global Transcatheter Structural Heart Device Market Research Report 2024

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1607471

No of Pages : 117

Synopsis
Structural Heart Device is used for Structural heart disease which is a problem with the tissues or valves of the heart. Many, structural heart diseases are congenital, which means present at birth. Some structural heart disease will develop later in life. Others disease like stroke can also be treated using left atrial appendage occluders which also has been included as structural heart device in this report

The global Transcatheter Structural Heart Device market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Transcatheter Structural Heart Device volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Structural Heart Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Transcatheter Structural Heart Device Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Left Atrial Appendage Occluders
Septal Defect Occluders
Aortic Valve Replacement
Mitral Valve Repair
Mitral Valve Replacement (Experimental)

Segment by Application
Congenital Heart Defects
Aortic Stenosis
Mitral Regurgitation
Stroke
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Medtronic
Boston Scientific Corporation
Abbott
Edwards Lifesciences Corporation
Lifetech
Braile Biomedica
Micro Interventional Devices
LivaNova PLC
Cryolife
Neovasc
4C Medical Technologies
Highlife
Lepu Medical
Dinova Medtech
NewMed Medical
Venus Medtech
Hanyu Medical
Index
1 Transcatheter Structural Heart Device Market Overview
1.1 Product Overview and Scope of Transcatheter Structural Heart Device
1.2 Transcatheter Structural Heart Device Segment by Type
1.2.1 Global Transcatheter Structural Heart Device Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Left Atrial Appendage Occluders
1.2.3 Septal Defect Occluders
1.2.4 Aortic Valve Replacement
1.2.5 Mitral Valve Repair
1.2.6 Mitral Valve Replacement (Experimental)
1.3 Transcatheter Structural Heart Device Segment by Application
1.3.1 Transcatheter Structural Heart Device Sales Comparison by Application: (2021-2027)
1.3.2 Congenital Heart Defects
1.3.3 Aortic Stenosis
1.3.4 Mitral Regurgitation
1.3.5 Stroke
1.3.6 Others
1.4 Global Transcatheter Structural Heart Device Market Size Estimates and Forecasts
1.4.1 Global Transcatheter Structural Heart Device Revenue 2016-2027
1.4.2 Global Transcatheter Structural Heart Device Sales 2016-2027
1.4.3 Transcatheter Structural Heart Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Transcatheter Structural Heart Device Market Competition by Manufacturers
2.1 Global Transcatheter Structural Heart Device Sales Market Share by Manufacturers (2016-2021)
2.2 Global Transcatheter Structural Heart Device Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Transcatheter Structural Heart Device Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Transcatheter Structural Heart Device Manufacturing Sites, Area Served, Product Type
2.5 Transcatheter Structural Heart Device Market Competitive Situation and Trends
2.5.1 Transcatheter Structural Heart Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Transcatheter Structural Heart Device Players Market Share by Revenue
2.5.3 Global Transcatheter Structural Heart Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Transcatheter Structural Heart Device Retrospective Market Scenario by Region
3.1 Global Transcatheter Structural Heart Device Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Transcatheter Structural Heart Device Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Transcatheter Structural Heart Device Market Facts & Figures by Country
3.3.1 North America Transcatheter Structural Heart Device Sales by Country
3.3.2 North America Transcatheter Structural Heart Device Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Transcatheter Structural Heart Device Market Facts & Figures by Country
3.4.1 Europe Transcatheter Structural Heart Device Sales by Country
3.4.2 Europe Transcatheter Structural Heart Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Transcatheter Structural Heart Device Market Facts & Figures by Region
3.5.1 Asia Pacific Transcatheter Structural Heart Device Sales by Region
3.5.2 Asia Pacific Transcatheter Structural Heart Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Transcatheter Structural Heart Device Market Facts & Figures by Country
3.6.1 Latin America Transcatheter Structural Heart Device Sales by Country
3.6.2 Latin America Transcatheter Structural Heart Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Transcatheter Structural Heart Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Transcatheter Structural Heart Device Sales by Country
3.7.2 Middle East and Africa Transcatheter Structural Heart Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Transcatheter Structural Heart Device Historic Market Analysis by Type
4.1 Global Transcatheter Structural Heart Device Sales Market Share by Type (2016-2021)
4.2 Global Transcatheter Structural Heart Device Revenue Market Share by Type (2016-2021)
4.3 Global Transcatheter Structural Heart Device Price by Type (2016-2021)

5 Global Transcatheter Structural Heart Device Historic Market Analysis by Application
5.1 Global Transcatheter Structural Heart Device Sales Market Share by Application (2016-2021)
5.2 Global Transcatheter Structural Heart Device Revenue Market Share by Application (2016-2021)
5.3 Global Transcatheter Structural Heart Device Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boston Scientific Corporation Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Edwards Lifesciences Corporation
6.4.1 Edwards Lifesciences Corporation Corporation Information
6.4.2 Edwards Lifesciences Corporation Description and Business Overview
6.4.3 Edwards Lifesciences Corporation Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Edwards Lifesciences Corporation Product Portfolio
6.4.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.5 Lifetech
6.5.1 Lifetech Corporation Information
6.5.2 Lifetech Description and Business Overview
6.5.3 Lifetech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lifetech Product Portfolio
6.5.5 Lifetech Recent Developments/Updates
6.6 Braile Biomedica
6.6.1 Braile Biomedica Corporation Information
6.6.2 Braile Biomedica Description and Business Overview
6.6.3 Braile Biomedica Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Braile Biomedica Product Portfolio
6.6.5 Braile Biomedica Recent Developments/Updates
6.7 Micro Interventional Devices
6.6.1 Micro Interventional Devices Corporation Information
6.6.2 Micro Interventional Devices Description and Business Overview
6.6.3 Micro Interventional Devices Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Micro Interventional Devices Product Portfolio
6.7.5 Micro Interventional Devices Recent Developments/Updates
6.8 LivaNova PLC
6.8.1 LivaNova PLC Corporation Information
6.8.2 LivaNova PLC Description and Business Overview
6.8.3 LivaNova PLC Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.8.4 LivaNova PLC Product Portfolio
6.8.5 LivaNova PLC Recent Developments/Updates
6.9 Cryolife
6.9.1 Cryolife Corporation Information
6.9.2 Cryolife Description and Business Overview
6.9.3 Cryolife Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Cryolife Product Portfolio
6.9.5 Cryolife Recent Developments/Updates
6.10 Neovasc
6.10.1 Neovasc Corporation Information
6.10.2 Neovasc Description and Business Overview
6.10.3 Neovasc Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Neovasc Product Portfolio
6.10.5 Neovasc Recent Developments/Updates
6.11 4C Medical Technologies
6.11.1 4C Medical Technologies Corporation Information
6.11.2 4C Medical Technologies Transcatheter Structural Heart Device Description and Business Overview
6.11.3 4C Medical Technologies Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.11.4 4C Medical Technologies Product Portfolio
6.11.5 4C Medical Technologies Recent Developments/Updates
6.12 Highlife
6.12.1 Highlife Corporation Information
6.12.2 Highlife Transcatheter Structural Heart Device Description and Business Overview
6.12.3 Highlife Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Highlife Product Portfolio
6.12.5 Highlife Recent Developments/Updates
6.13 Lepu Medical
6.13.1 Lepu Medical Corporation Information
6.13.2 Lepu Medical Transcatheter Structural Heart Device Description and Business Overview
6.13.3 Lepu Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Lepu Medical Product Portfolio
6.13.5 Lepu Medical Recent Developments/Updates
6.14 Dinova Medtech
6.14.1 Dinova Medtech Corporation Information
6.14.2 Dinova Medtech Transcatheter Structural Heart Device Description and Business Overview
6.14.3 Dinova Medtech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Dinova Medtech Product Portfolio
6.14.5 Dinova Medtech Recent Developments/Updates
6.15 NewMed Medical
6.15.1 NewMed Medical Corporation Information
6.15.2 NewMed Medical Transcatheter Structural Heart Device Description and Business Overview
6.15.3 NewMed Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.15.4 NewMed Medical Product Portfolio
6.15.5 NewMed Medical Recent Developments/Updates
6.16 Venus Medtech
6.16.1 Venus Medtech Corporation Information
6.16.2 Venus Medtech Transcatheter Structural Heart Device Description and Business Overview
6.16.3 Venus Medtech Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Venus Medtech Product Portfolio
6.16.5 Venus Medtech Recent Developments/Updates
6.17 Hanyu Medical
6.17.1 Hanyu Medical Corporation Information
6.17.2 Hanyu Medical Transcatheter Structural Heart Device Description and Business Overview
6.17.3 Hanyu Medical Transcatheter Structural Heart Device Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Hanyu Medical Product Portfolio
6.17.5 Hanyu Medical Recent Developments/Updates

7 Transcatheter Structural Heart Device Manufacturing Cost Analysis
7.1 Transcatheter Structural Heart Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Transcatheter Structural Heart Device
7.4 Transcatheter Structural Heart Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Transcatheter Structural Heart Device Distributors List
8.3 Transcatheter Structural Heart Device Customers

9 Transcatheter Structural Heart Device Market Dynamics
9.1 Transcatheter Structural Heart Device Industry Trends
9.2 Transcatheter Structural Heart Device Growth Drivers
9.3 Transcatheter Structural Heart Device Market Challenges
9.4 Transcatheter Structural Heart Device Market Restraints

10 Global Market Forecast
10.1 Transcatheter Structural Heart Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Type (2022-2027)
10.2 Transcatheter Structural Heart Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Application (2022-2027)
10.3 Transcatheter Structural Heart Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Transcatheter Structural Heart Device by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Transcatheter Structural Heart Device by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Transcatheter Structural Heart Device Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Transcatheter Structural Heart Device Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Transcatheter Structural Heart Device Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Transcatheter Structural Heart Device Covered in This Study
Table 5. Global Transcatheter Structural Heart Device Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Transcatheter Structural Heart Device Sales Share by Manufacturers (2016-2021)
Table 7. Global Transcatheter Structural Heart Device Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Transcatheter Structural Heart Device Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Transcatheter Structural Heart Device Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Transcatheter Structural Heart Device Manufacturing Sites and Area Served
Table 11. Manufacturers Transcatheter Structural Heart Device Product Type
Table 12. Global Transcatheter Structural Heart Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Transcatheter Structural Heart Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transcatheter Structural Heart Device as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Transcatheter Structural Heart Device Sales by Region (2016-2021) & (K Units)
Table 16. Global Transcatheter Structural Heart Device Sales Market Share by Region (2016-2021)
Table 17. Global Transcatheter Structural Heart Device Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Transcatheter Structural Heart Device Sales by Country (2016-2021) & (K Units)
Table 19. North America Transcatheter Structural Heart Device Sales Market Share by Country (2016-2021)
Table 20. North America Transcatheter Structural Heart Device Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Transcatheter Structural Heart Device Revenue Market Share by Country (2016-2021)
Table 22. Europe Transcatheter Structural Heart Device Sales by Country (2016-2021) & (K Units)
Table 23. Europe Transcatheter Structural Heart Device Sales Market Share by Country (2016-2021)
Table 24. Europe Transcatheter Structural Heart Device Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Transcatheter Structural Heart Device Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Transcatheter Structural Heart Device Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Transcatheter Structural Heart Device Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Transcatheter Structural Heart Device Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Transcatheter Structural Heart Device Revenue Market Share by Region (2016-2021)
Table 30. Latin America Transcatheter Structural Heart Device Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Transcatheter Structural Heart Device Sales Market Share by Country (2016-2021)
Table 32. Latin America Transcatheter Structural Heart Device Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Transcatheter Structural Heart Device Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Transcatheter Structural Heart Device Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Transcatheter Structural Heart Device Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Transcatheter Structural Heart Device Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Transcatheter Structural Heart Device Revenue Market Share by Country (2016-2021)
Table 38. Global Transcatheter Structural Heart Device Sales (K Units) by Type (2016-2021)
Table 39. Global Transcatheter Structural Heart Device Sales Market Share by Type (2016-2021)
Table 40. Global Transcatheter Structural Heart Device Revenue (Million US$) by Type (2016-2021)
Table 41. Global Transcatheter Structural Heart Device Revenue Share by Type (2016-2021)
Table 42. Global Transcatheter Structural Heart Device Price (US$/Unit) by Type (2016-2021)
Table 43. Global Transcatheter Structural Heart Device Sales (K Units) by Application (2016-2021)
Table 44. Global Transcatheter Structural Heart Device Sales Market Share by Application (2016-2021)
Table 45. Global Transcatheter Structural Heart Device Revenue (Million US$) by Application (2016-2021)
Table 46. Global Transcatheter Structural Heart Device Revenue Share by Application (2016-2021)
Table 47. Global Transcatheter Structural Heart Device Price (US$/Unit) by Application (2016-2021)
Table 48. Medtronic Corporation Information
Table 49. Medtronic Description and Business Overview
Table 50. Medtronic Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic Transcatheter Structural Heart Device Product
Table 52. Medtronic Recent Developments/Updates
Table 53. Boston Scientific Corporation Corporation Information
Table 54. Boston Scientific Corporation Description and Business Overview
Table 55. Boston Scientific Corporation Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Boston Scientific Corporation Transcatheter Structural Heart Device Product
Table 57. Boston Scientific Corporation Recent Developments/Updates
Table 58. Abbott Corporation Information
Table 59. Abbott Description and Business Overview
Table 60. Abbott Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Abbott Transcatheter Structural Heart Device Product
Table 62. Abbott Recent Developments/Updates
Table 63. Edwards Lifesciences Corporation Corporation Information
Table 64. Edwards Lifesciences Corporation Description and Business Overview
Table 65. Edwards Lifesciences Corporation Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Edwards Lifesciences Corporation Transcatheter Structural Heart Device Product
Table 67. Edwards Lifesciences Corporation Recent Developments/Updates
Table 68. Lifetech Corporation Information
Table 69. Lifetech Description and Business Overview
Table 70. Lifetech Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Lifetech Transcatheter Structural Heart Device Product
Table 72. Lifetech Recent Developments/Updates
Table 73. Braile Biomedica Corporation Information
Table 74. Braile Biomedica Description and Business Overview
Table 75. Braile Biomedica Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Braile Biomedica Transcatheter Structural Heart Device Product
Table 77. Braile Biomedica Recent Developments/Updates
Table 78. Micro Interventional Devices Corporation Information
Table 79. Micro Interventional Devices Description and Business Overview
Table 80. Micro Interventional Devices Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Micro Interventional Devices Transcatheter Structural Heart Device Product
Table 82. Micro Interventional Devices Recent Developments/Updates
Table 83. LivaNova PLC Corporation Information
Table 84. LivaNova PLC Description and Business Overview
Table 85. LivaNova PLC Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. LivaNova PLC Transcatheter Structural Heart Device Product
Table 87. LivaNova PLC Recent Developments/Updates
Table 88. Cryolife Corporation Information
Table 89. Cryolife Description and Business Overview
Table 90. Cryolife Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Cryolife Transcatheter Structural Heart Device Product
Table 92. Cryolife Recent Developments/Updates
Table 93. Neovasc Corporation Information
Table 94. Neovasc Description and Business Overview
Table 95. Neovasc Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Neovasc Transcatheter Structural Heart Device Product
Table 97. Neovasc Recent Developments/Updates
Table 98. 4C Medical Technologies Corporation Information
Table 99. 4C Medical Technologies Description and Business Overview
Table 100. 4C Medical Technologies Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. 4C Medical Technologies Transcatheter Structural Heart Device Product
Table 102. 4C Medical Technologies Recent Developments/Updates
Table 103. Highlife Corporation Information
Table 104. Highlife Description and Business Overview
Table 105. Highlife Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Highlife Transcatheter Structural Heart Device Product
Table 107. Highlife Recent Developments/Updates
Table 108. Lepu Medical Corporation Information
Table 109. Lepu Medical Description and Business Overview
Table 110. Lepu Medical Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Lepu Medical Transcatheter Structural Heart Device Product
Table 112. Lepu Medical Recent Developments/Updates
Table 113. Dinova Medtech Corporation Information
Table 114. Dinova Medtech Description and Business Overview
Table 115. Dinova Medtech Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Dinova Medtech Transcatheter Structural Heart Device Product
Table 117. Dinova Medtech Recent Developments/Updates
Table 118. NewMed Medical Corporation Information
Table 119. NewMed Medical Description and Business Overview
Table 120. NewMed Medical Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. NewMed Medical Transcatheter Structural Heart Device Product
Table 122. NewMed Medical Recent Developments/Updates
Table 123. Venus Medtech Corporation Information
Table 124. Venus Medtech Description and Business Overview
Table 125. Venus Medtech Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Venus Medtech Transcatheter Structural Heart Device Product
Table 127. Venus Medtech Recent Developments/Updates
Table 128. Hanyu Medical Corporation Information
Table 129. Hanyu Medical Description and Business Overview
Table 130. Hanyu Medical Transcatheter Structural Heart Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Hanyu Medical Transcatheter Structural Heart Device Product
Table 132. Hanyu Medical Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Transcatheter Structural Heart Device Distributors List
Table 136. Transcatheter Structural Heart Device Customers List
Table 137. Transcatheter Structural Heart Device Market Trends
Table 138. Transcatheter Structural Heart Device Growth Drivers
Table 139. Transcatheter Structural Heart Device Market Restraints
Table 140. Global Transcatheter Structural Heart Device Sales Forecast by Type (2022-2027) & (K Units)
Table 141. Global Transcatheter Structural Heart Device Sales Market Share Forecast by Type (2022-2027)
Table 142. Global Transcatheter Structural Heart Device Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 143. Global Transcatheter Structural Heart Device Revenue Market Share Forecast by Type (2022-2027)
Table 144. Global Transcatheter Structural Heart Device Sales Forecast by Application (2022-2027) & (K Units)
Table 145. Global Transcatheter Structural Heart Device Sales Market Share Forecast by Application (2022-2027)
Table 146. Global Transcatheter Structural Heart Device Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 147. Global Transcatheter Structural Heart Device Revenue Market Share Forecast by Application (2022-2027)
Table 148. Global Transcatheter Structural Heart Device Sales Forecast by Region (2022-2027) & (K Units)
Table 149. Global Transcatheter Structural Heart Device Sales Market Share Forecast by Region (2022-2027)
Table 150. Global Transcatheter Structural Heart Device Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 151. Global Transcatheter Structural Heart Device Revenue Market Share Forecast by Region (2022-2027)
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Transcatheter Structural Heart Device
Figure 2. Global Transcatheter Structural Heart Device Market Share by Type in 2020 & 2027
Figure 3. Left Atrial Appendage Occluders Product Picture
Figure 4. Septal Defect Occluders Product Picture
Figure 5. Aortic Valve Replacement Product Picture
Figure 6. Mitral Valve Repair Product Picture
Figure 7. Mitral Valve Replacement (Experimental) Product Picture
Figure 8. Global Transcatheter Structural Heart Device Market Share by Application in 2020 & 2027
Figure 9. Congenital Heart Defects
Figure 10. Aortic Stenosis
Figure 11. Mitral Regurgitation
Figure 12. Stroke
Figure 13. Others
Figure 14. Global Transcatheter Structural Heart Device Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Transcatheter Structural Heart Device Market Size 2016-2027 (US$ Million)
Figure 16. Global Transcatheter Structural Heart Device Sales 2016-2027 (K Units)
Figure 17. Global Transcatheter Structural Heart Device Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Transcatheter Structural Heart Device Sales Share by Manufacturers in 2020
Figure 19. Global Transcatheter Structural Heart Device Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Transcatheter Structural Heart Device Players: Market Share by Revenue in 2020
Figure 21. Transcatheter Structural Heart Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Transcatheter Structural Heart Device Sales Market Share by Region (2016-2021)
Figure 23. Global Transcatheter Structural Heart Device Sales Market Share by Region in 2020
Figure 24. Global Transcatheter Structural Heart Device Revenue Market Share by Region (2016-2021)
Figure 25. Global Transcatheter Structural Heart Device Revenue Market Share by Region in 2020
Figure 26. U.S. Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. UAE Transcatheter Structural Heart Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Transcatheter Structural Heart Device by Type (2016-2021)
Figure 51. Sales Market Share of Transcatheter Structural Heart Device by Application (2016-2021)
Figure 52. Sales Market Share of Transcatheter Structural Heart Device by Application in 2020
Figure 53. Revenue Share of Transcatheter Structural Heart Device by Application (2016-2021)
Figure 54. Revenue Share of Transcatheter Structural Heart Device by Application in 2020
Figure 55. Manufacturing Cost Structure of Transcatheter Structural Heart Device
Figure 56. Manufacturing Process Analysis of Transcatheter Structural Heart Device
Figure 57. Transcatheter Structural Heart Device Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’